Vizgen Issued a New US Patent for Its MERFISH Technology

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, announced today the issuance by the US Patent Office of a patent that covers the in situ imaging of the spatial transcriptome. U.S. Patent No. 11,959,075 is for robust multiplex imaging of RNA and its spatial organization in a sample. “This latest patent relates to our MERFISH technology and enables groundbreaking advancements in
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks